Characteristics of Proton Pump Inhibitors Utilization in Postacute Phase of Ischemic Heart Disease

Cardiologia Croatica - Croatia
doi 10.15836/ccar.2014.418
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Medical Publishing, d.o.o.

Related search

Proton Pump Inhibitors in Kidney Disease

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Use of Proton Pump Inhibitors and Subsequent Risk of Celiac Disease

Digestive and Liver Disease
HepatologyGastroenterology
2014English

The Relationship Between Proton Pump Inhibitors and Renal Disease

Jornal brasileiro de nefrologia : orgão oficial de Sociedades Brasileira e Latino-Americana de Nefrologia
Medicine
2018English

Choice of Optimal Proton Pump Inhibitor for Patients With Ischemic Heart Disease Who Require Dual Antiplatelet Therapy

HYPERTENSION
2018English

Pleotropic Effects of Proton Pump Inhibitors Guest Editor: Yuji Naito Endoscopic Submucosal Dissection in the Era of Proton Pump Inhibitors

Journal of Clinical Biochemistry and Nutrition
MedicineNutritionClinical BiochemistryDietetics
2009English

Use of Proton Pump Inhibitors in Chronic Liver Diseases

Clinical Liver Disease
Hepatology
2017English

Imprudent Use of Proton Pump Inhibitors in Current Practice

International Journal of Basic & Clinical Pharmacology
2015English

Proton Pump Inhibitors and Gastric Neoplasia

Gut
Gastroenterology
2006English

The Role of Proton Pump Inhibitors in Renal Disease - The Risk of Using OTC Drugs

Farmacja Polska
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy